Abstract:Background: Epithelial-mesenchymal transition (EMT) plays a key role in tubulointerstitial fibrosis, which is a hallmark of diabetic kidney disease (DKD). Our previous studies showed that CRTC2 can simultaneously regulate glucose metabolism and lipid metabolism. However, it is still unclear whether CRTC2 participates in the EMT process in DKD. Methods: We used protein‒protein network (PPI) analysis to identify genes that were differentially expressed during DKD and EMT. Then, we constructed a diabetic mouse model by administering STZ plus a high-fat diet, and we used HK-2 cells that were verified to confirm the bioinformatics research results. The effects that were exerted by CRTC2 on epithelial-mesenchymal transition in diabetic kidney disease through the CREB-Smad2/3 signaling pathway were investigated in vivo and in vitro by real-time PCR, WB, IHC and double luciferase reporter gene experiments. Results: First, bioinformatics research showed that CRTC2 may promote EMT in diabetic renal tubules through the CREB-Smad2/3 signaling pathway. Furthermore, the Western blotting and real-time PCR results showed that CRTC2 overexpression reduced the expression of E-cadherin in HK-2 cells. The CRTC2 and α-SMA levels were increased in STZ-treated mouse kidneys, and the E-cadherin level was reduced. The luciferase activity of α-SMA, which is the key protein in EMT, was sharply increased in response to the overexpression of CRTC2 and decreased after the silencing of CREB and Smad2/3. However, the expression of E-cadherin showed the opposite trends. In the real-time PCR experiment, the mRNA expression of α-SMA increased significantly when CRTC2 was overexpressed but partially decreased when CREB and Smad2/3 were silenced. However, E-cadherin expression showed the opposite result. Conclusion: This study demonstrated that CRTC2 activates the EMT process via the CREB-Smad2/3 signaling pathway in diabetic renal tubules.

The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1

CRTC3 Regulates the Lipid Metabolism and Adipogenic Differentiation of Porcine Intramuscular and Subcutaneous Adipocytes by Activating the Calcium Pathway.

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Targeted Disruption Of The Creb Coactivator Crtc2 Increases Insulin Sensitivity

cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis

CRTCs:an Essential Coactivator Family of CREB Regulated Transcription

CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice

The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis

CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway

The CRTC-CREB axis functions as a transcriptional sensor to protect against proteotoxic stress in Drosophila

Regulation of Lipogenesis by Cyclin-Dependent Kinase 8-Mediated Control of SREBP-1.

Transcription factor CREB3 is a potent regulator of high-fat diet-induced obesity and energy metabolism

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance

β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism

The Creb Coactivator Torc2 is A Key Regulator of Fasting Glucose Metabolism

TET2 is recruited by CREB to promote Cebpb, Cebpa, and Pparg transcription by facilitating hydroxymethylation during adipocyte differentiation

Regulation Role of CRTC3 in Skeletal Muscle and Adipose Tissue

Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells

The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes